nodes	percent_of_prediction	percent_of_DWPC	metapath
Droperidol—Consciousness abnormal—Vincristine—colon cancer	0.0882	0.131	CcSEcCtD
Droperidol—HTR2A—myenteric nerve plexus—colon cancer	0.0821	0.279	CbGeAlD
Droperidol—HTR2A—vein—colon cancer	0.0529	0.18	CbGeAlD
Droperidol—Hypovolaemia—Irinotecan—colon cancer	0.0481	0.0714	CcSEcCtD
Droperidol—Altered state of consciousness—Vincristine—colon cancer	0.0331	0.0493	CcSEcCtD
Droperidol—Sudden death—Irinotecan—colon cancer	0.0291	0.0433	CcSEcCtD
Droperidol—Sudden death—Fluorouracil—colon cancer	0.0279	0.0414	CcSEcCtD
Droperidol—Akathisia—Irinotecan—colon cancer	0.0269	0.04	CcSEcCtD
Droperidol—Shivering—Capecitabine—colon cancer	0.0268	0.0398	CcSEcCtD
Droperidol—Inappropriate antidiuretic hormone secretion—Vincristine—colon cancer	0.0263	0.0391	CcSEcCtD
Droperidol—Altered state of consciousness—Capecitabine—colon cancer	0.0216	0.0321	CcSEcCtD
Droperidol—Sudden death—Capecitabine—colon cancer	0.0195	0.029	CcSEcCtD
Droperidol—HTR2A—endothelium—colon cancer	0.0182	0.0618	CbGeAlD
Droperidol—HTR2A—blood vessel—colon cancer	0.0168	0.057	CbGeAlD
Droperidol—Sudden death—Methotrexate—colon cancer	0.0145	0.0216	CcSEcCtD
Droperidol—Torsade de pointes—Capecitabine—colon cancer	0.0142	0.0211	CcSEcCtD
Droperidol—Fenbufen—PTGS2—colon cancer	0.0138	0.427	CrCbGaD
Droperidol—ADRA1A—epithelium—colon cancer	0.0126	0.0429	CbGeAlD
Droperidol—ADRA1A—renal system—colon cancer	0.0117	0.0398	CbGeAlD
Droperidol—KCNH2—renal system—colon cancer	0.0113	0.0384	CbGeAlD
Droperidol—Cardiac arrest—Vincristine—colon cancer	0.0106	0.0157	CcSEcCtD
Droperidol—Cardiac arrest—Irinotecan—colon cancer	0.0103	0.0153	CcSEcCtD
Droperidol—HTR2A—embryo—colon cancer	0.01	0.034	CbGeAlD
Droperidol—Blood pressure increased—Capecitabine—colon cancer	0.00997	0.0148	CcSEcCtD
Droperidol—Cardiac arrest—Fluorouracil—colon cancer	0.00985	0.0146	CcSEcCtD
Droperidol—ADRA1A—lymphoid tissue—colon cancer	0.00974	0.033	CbGeAlD
Droperidol—KCNH2—bone marrow—colon cancer	0.00857	0.0291	CbGeAlD
Droperidol—Depression—Vincristine—colon cancer	0.00853	0.0127	CcSEcCtD
Droperidol—KCNH2—vagina—colon cancer	0.00821	0.0278	CbGeAlD
Droperidol—HTR2A—epithelium—colon cancer	0.00818	0.0277	CbGeAlD
Droperidol—HTR2A—smooth muscle tissue—colon cancer	0.00788	0.0267	CbGeAlD
Droperidol—Hallucination—Vincristine—colon cancer	0.00765	0.0114	CcSEcCtD
Droperidol—HTR2A—renal system—colon cancer	0.00758	0.0257	CbGeAlD
Droperidol—ADRA1A—liver—colon cancer	0.00717	0.0243	CbGeAlD
Droperidol—Domperidone—ABCB1—colon cancer	0.00712	0.221	CrCbGaD
Droperidol—Cardiac arrest—Capecitabine—colon cancer	0.00688	0.0102	CcSEcCtD
Droperidol—Chills—Irinotecan—colon cancer	0.00671	0.00998	CcSEcCtD
Droperidol—Gynaecomastia—Methotrexate—colon cancer	0.00664	0.00987	CcSEcCtD
Droperidol—HTR2A—digestive system—colon cancer	0.00622	0.0211	CbGeAlD
Droperidol—Bronchospasm—Capecitabine—colon cancer	0.00615	0.00915	CcSEcCtD
Droperidol—Pimozide—ABCB1—colon cancer	0.00595	0.184	CrCbGaD
Droperidol—Syncope—Irinotecan—colon cancer	0.00584	0.00868	CcSEcCtD
Droperidol—Hypertension—Vincristine—colon cancer	0.00578	0.00858	CcSEcCtD
Droperidol—Loss of consciousness—Irinotecan—colon cancer	0.00573	0.00851	CcSEcCtD
Droperidol—Hyperglycaemia—Capecitabine—colon cancer	0.00564	0.00839	CcSEcCtD
Droperidol—Hypertension—Irinotecan—colon cancer	0.00562	0.00836	CcSEcCtD
Droperidol—Depression—Capecitabine—colon cancer	0.00556	0.00827	CcSEcCtD
Droperidol—HTR2A—vagina—colon cancer	0.00549	0.0186	CbGeAlD
Droperidol—Anaphylactic shock—Vincristine—colon cancer	0.00546	0.00811	CcSEcCtD
Droperidol—Haloperidol—ABCB1—colon cancer	0.00543	0.168	CrCbGaD
Droperidol—Anaphylactic shock—Irinotecan—colon cancer	0.00532	0.0079	CcSEcCtD
Droperidol—KCNH2—lymph node—colon cancer	0.00531	0.018	CbGeAlD
Droperidol—Shock—Irinotecan—colon cancer	0.00523	0.00777	CcSEcCtD
Droperidol—Hypotension—Vincristine—colon cancer	0.0051	0.00758	CcSEcCtD
Droperidol—Anaphylactic shock—Fluorouracil—colon cancer	0.00509	0.00757	CcSEcCtD
Droperidol—Tachycardia—Fluorouracil—colon cancer	0.00497	0.00739	CcSEcCtD
Droperidol—Hypotension—Irinotecan—colon cancer	0.00497	0.00738	CcSEcCtD
Droperidol—Hypotension—Fluorouracil—colon cancer	0.00476	0.00707	CcSEcCtD
Droperidol—Somnolence—Irinotecan—colon cancer	0.00473	0.00702	CcSEcCtD
Droperidol—HTR2A—liver—colon cancer	0.00463	0.0157	CbGeAlD
Droperidol—Somnolence—Fluorouracil—colon cancer	0.00453	0.00673	CcSEcCtD
Droperidol—Chills—Capecitabine—colon cancer	0.00449	0.00668	CcSEcCtD
Droperidol—Body temperature increased—Vincristine—colon cancer	0.00432	0.00641	CcSEcCtD
Droperidol—Body temperature increased—Irinotecan—colon cancer	0.0042	0.00625	CcSEcCtD
Droperidol—Drowsiness—Methotrexate—colon cancer	0.00415	0.00617	CcSEcCtD
Droperidol—Depression—Methotrexate—colon cancer	0.00414	0.00615	CcSEcCtD
Droperidol—Body temperature increased—Fluorouracil—colon cancer	0.00403	0.00598	CcSEcCtD
Droperidol—Hypersensitivity—Vincristine—colon cancer	0.00402	0.00598	CcSEcCtD
Droperidol—Hypersensitivity—Irinotecan—colon cancer	0.00392	0.00582	CcSEcCtD
Droperidol—Syncope—Capecitabine—colon cancer	0.00391	0.00581	CcSEcCtD
Droperidol—Palpitations—Capecitabine—colon cancer	0.00385	0.00573	CcSEcCtD
Droperidol—Loss of consciousness—Capecitabine—colon cancer	0.00383	0.00569	CcSEcCtD
Droperidol—Hypertension—Capecitabine—colon cancer	0.00376	0.00559	CcSEcCtD
Droperidol—Hypersensitivity—Fluorouracil—colon cancer	0.00375	0.00557	CcSEcCtD
Droperidol—Anxiety—Capecitabine—colon cancer	0.0037	0.0055	CcSEcCtD
Droperidol—Dizziness—Vincristine—colon cancer	0.00361	0.00536	CcSEcCtD
Droperidol—Dizziness—Irinotecan—colon cancer	0.00352	0.00522	CcSEcCtD
Droperidol—Shock—Capecitabine—colon cancer	0.0035	0.0052	CcSEcCtD
Droperidol—Tachycardia—Capecitabine—colon cancer	0.00347	0.00516	CcSEcCtD
Droperidol—Rash—Vincristine—colon cancer	0.00344	0.00512	CcSEcCtD
Droperidol—Dermatitis—Vincristine—colon cancer	0.00344	0.00511	CcSEcCtD
Droperidol—Dizziness—Fluorouracil—colon cancer	0.00337	0.005	CcSEcCtD
Droperidol—Rash—Irinotecan—colon cancer	0.00335	0.00498	CcSEcCtD
Droperidol—Dermatitis—Irinotecan—colon cancer	0.00335	0.00498	CcSEcCtD
Droperidol—Chills—Methotrexate—colon cancer	0.00335	0.00497	CcSEcCtD
Droperidol—Hypotension—Capecitabine—colon cancer	0.00332	0.00494	CcSEcCtD
Droperidol—Rash—Fluorouracil—colon cancer	0.00321	0.00477	CcSEcCtD
Droperidol—Dermatitis—Fluorouracil—colon cancer	0.00321	0.00477	CcSEcCtD
Droperidol—Body temperature increased—Capecitabine—colon cancer	0.00281	0.00418	CcSEcCtD
Droperidol—Anaphylactic shock—Methotrexate—colon cancer	0.00265	0.00394	CcSEcCtD
Droperidol—Hypersensitivity—Capecitabine—colon cancer	0.00262	0.0039	CcSEcCtD
Droperidol—Hypotension—Methotrexate—colon cancer	0.00248	0.00368	CcSEcCtD
Droperidol—Somnolence—Methotrexate—colon cancer	0.00235	0.0035	CcSEcCtD
Droperidol—Dizziness—Capecitabine—colon cancer	0.00235	0.0035	CcSEcCtD
Droperidol—Rash—Capecitabine—colon cancer	0.00224	0.00333	CcSEcCtD
Droperidol—Dermatitis—Capecitabine—colon cancer	0.00224	0.00333	CcSEcCtD
Droperidol—Body temperature increased—Methotrexate—colon cancer	0.00209	0.00311	CcSEcCtD
Droperidol—Hypersensitivity—Methotrexate—colon cancer	0.00195	0.0029	CcSEcCtD
Droperidol—Dizziness—Methotrexate—colon cancer	0.00175	0.0026	CcSEcCtD
Droperidol—Rash—Methotrexate—colon cancer	0.00167	0.00248	CcSEcCtD
Droperidol—Dermatitis—Methotrexate—colon cancer	0.00167	0.00248	CcSEcCtD
